Assessing Clinuvel Pharmaceuticals' Valuation As VLRX L Enters Its First Preclinical Dosing Study [Yahoo! Finance]
CLINUVEL PHARMS LTD S/ADR (CLVLY)
NASDAQ:AMEX Investor Relations:
clinuvel.com/investors
Company Research
Source: Yahoo! Finance
This marks the first formal test of its next-generation delivery technology. See our latest analysis for Clinuvel Pharmaceuticals. Despite the VLRX-L update, Clinuvel Pharmaceuticals' share price, last closed at A$12.23, has had a mixed run, with a 90 day share price return of 2.0%, a 1 year total shareholder return of 4.6%, and a 3 year total shareholder return decline of 53.7%. This suggests longer term momentum has been weak even as interest around new pipeline progress may be starting to rebuild. If you are looking beyond a single biotech story, this could be a useful moment to scan other healthcare stocks that might fit your approach. With A$95.02m in revenue, A$36.17m in net income and a value score of 3, plus an indicated intrinsic discount of 82%, the key question is whether Clinuvel is underappreciated or if markets are already pricing in future growth. Clinuvel Pharmaceuticals' most followed narrative points to a fair value around A$23.87 compared with the last clo
Show less
Read more
Impact Snapshot
Event Time:
CLVLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLVLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLVLY alerts
High impacting CLINUVEL PHARMS LTD S/ADR news events
Weekly update
A roundup of the hottest topics
CLVLY
News
- Will VLRX-L Preclinical Dosing Signal a New Pipeline Chapter for Clinuvel Pharmaceuticals (ASX:CUV) Narrative [Yahoo! Finance]Yahoo! Finance
- Exploring Three High Growth Tech Stocks In Australia [Yahoo! Finance]Yahoo! Finance
- Artrya And 2 Other High Growth Tech Stocks With Potential In Australia [Yahoo! Finance]Yahoo! Finance
- ASX Growth Stocks With High Insider Ownership December 2025 [Yahoo! Finance]Yahoo! Finance
- Exploring High Growth Tech Stocks in Australia Featuring Three Prominent Companies [Yahoo! Finance]Yahoo! Finance